Reyon Pharmaceutical

이연제약KRX: 102460· Fiscal year 2025· reyonpharm.co.kr ↗

Average salary
$57.3K
₩76.4M
▼ 11.9% vs 2024
Employees
457
▲ 1.8% vs 2024
Average tenure
Not disclosed

Estimated take-home of this pay:$3.9K / monthCalculate →

Workplace

Women's pay (men = 100)55
Women among staff32.4%
Contract staff1.1%

Recent official filings

Quick read

  • Average pay is 25% above the median of the companies we track.
  • Average pay fell 11.9% from 2024.
  • Headcount grew by 8 (1.8%) from 2024.
  • Ranks #32 of 238 Healthcare & Pharma companies in this country by pay.
  • Revenue fell 1.6% year over year.
  • Revenue has shrunk two years in a row.
  • Operating loss of $22.7M in 2025.

Last 3 years

Revenue
$113.4M2023$111.3M2024$109.5M2025
Operating income
$3.0M2023$59.5K2024-$22.7M2025

See the share price on Naver Finance ↗

Investor metrics

2025
Revenue per employee
$239.1K
Net profit per employee
-$48.6K
Operating margin
-20.7%
Net margin
-20.3%
ROE
-13.5%
Debt-to-equity
111.1%
Equity ratio
47.4%

Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.

Similar companies

USD at ₩1,332.22 per $1 (2026-11-19, ExchangeRate-API)

Source: DART (Financial Supervisory Service, Korea)

Not investment advice. Figures come from public filings and may contain errors.